Cargando…

Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease

Detalles Bibliográficos
Autores principales:	Feng, Jin, Meir, Lea, Ghaw, Olivia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Letter to the Editor (Case report)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188300/ https://www.ncbi.nlm.nih.gov/pubmed/37207268 http://dx.doi.org/10.1093/rap/rkad046

Ejemplares similares

Mycophenolate mofetil and telmisartan for the treatment of proteinuria secondary to minimal change disease podocytopathy in a dog
por: Travail, Victoria, et al.
Publicado: (2022)

The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever
por: Sozeri, Betul, et al.
Publicado: (2016)

Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Recalcitrant Esophageal Stricture Secondary to Mycophenolate Mofetil
por: Kim, Joyce J., et al.
Publicado: (2020)

Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis
por: Almutairi, Abdulaziz, et al.
Publicado: (2018)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Mycophenolate mofetil as a possible therapeutic option for idiopathic membranoproliferative glomerulonephritis
por: Kazory, Amir, et al.
Publicado: (2008)

Recalcitrant urticaria controlled with a combination of mycophenolate mofetil and sulfasalazine
por: Ashbaugh, Alyssa G., et al.
Publicado: (2021)

Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil
por: Young, Kelly Z., et al.
Publicado: (2022)

Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease
por: Galozzi, Paola, et al.
Publicado: (2018)

Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
por: Falcini, FF, et al.
Publicado: (2008)

Effect of Mycophenolate Mofetil on Plasma Bioelements in Renal Transplant Recipients
por: Kamińska, Jolanta, et al.
Publicado: (2011)

MANAGEMENT OF ERYTHEMA NODOSUM LEPROSUM BY MYCOPHENOLATE MOFETIL
por: Banerjee, Kalyan, et al.
Publicado: (2008)

Acute Mycophenolate Mofetil Overdose Managed Conservatively
por: Sharma, Prabhat, et al.
Publicado: (2021)

Overdose of mycophenolate mofetil managed in a secondary care hospital in South India
por: Alex, Reginald, et al.
Publicado: (2014)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)

Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)

Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis
por: Ostalska-Nowicka, Danuta, et al.
Publicado: (2011)

COVID-19 Vaccination Response in Kidney Transplant Recipients With and Without Mycophenolate Mofetil: Follow-up of a Randomized Controlled Trial
por: Al Fatly, Zainab, et al.
Publicado: (2022)

The Influence of Mycophenolate Mofetil and Azathioprine on the Same Cadaveric Donor Renal Transplantation
por: Joh, Jae Won, et al.
Publicado: (2005)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013)

Effect of Combined Intravenous Immunoglobulin and Mycophenolate Mofetil in a Pediatric Patient With Highly Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Severe Proteinuria Secondary to Amyloidosis Requiring Bilateral Renal Artery Embolization
por: Yeh, Chun-Tung, et al.
Publicado: (2012)

Secondary Renal Amyloidosis in Adult Onset Still’s Disease: Case report and Review of the Literature
por: Oh, Young Bae, et al.
Publicado: (2000)

Perforated Jejunal Diverticulum in the Use of Mycophenolate Mofetil
por: Thongprayoon, Charat, et al.
Publicado: (2014)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
por: Park, Seung Woon, et al.
Publicado: (2016)

Deep Ulcers in the Ileum Associated with Mycophenolate Mofetil
por: Sonoda, Akira, et al.
Publicado: (2017)

Idiopathic membranoproliferative glomerulonephritis treated with mycophenolate mofetil
por: Koratala, Abhilash, et al.
Publicado: (2018)

Treatment of Kimura disease with mycophenolate mofetil monotherapy
por: Shah, Kalee, et al.
Publicado: (2017)

Mycophenolate mofetil product monograph updated in Canada
Publicado: (2021)

Mycophenolate-mofetil/valganciclovir: Neutropenia: case report
Publicado: (2022)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
por: Yim, Rebecca M., et al.
Publicado: (2023)

Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease
por: Vitale, Antonio, et al.
Publicado: (2020)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome
por: Farruggia, Piero, et al.
Publicado: (2011)

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini, G, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_s9jv4b6s6alc1c8ktkf8695ieb